The new European EP PerMed partnership in precision medicine begins with the participation of ISCIII

The new EP PerMed partnership promoted by the European Union under the Horizon Europe research framework program began taking its first steps in January this year. The Carlos III Health Institute (ISCIII) is actively involved in this partnership and will invest 28 million euros over the next seven years, that is, it will finance one call per year, including three million for the first call on targets and biomarkers.

EP PerMed Searches Promote the development of personalized medicine Facilitating advances in prevention, diagnosis and treatment that can improve the personalized clinical approach to various diseases. Its total budget is approximately €375 million for the next seven years, provided in a co-financing model by the European Union and more than 50 international partners, including ISCIII.

the First call for EP PerMed To finance projects, called “Identifying and validating the goals of personalized medicine”, has just been released. On January 2 was the official opening, on June 12 the deadline for submitting initial proposals for funding for research projects began, and after the first review, on June 20, the deadline for submitting final proposals ends.

The three million euros that ISCIII will contribute to this first call can be accessed by research centres, hospitals, health research institutes (IIS), groups from the Center for Biomedical Research Network (CIBER), foundations and universities.

A push for precision medicine

ISCIII's participation in EP PerMed reinforces its commitment to promoting precision medicine in Spain, in line with what was identified in its Strategic Plan 2021-2025.

“The launch of this European Personalized Medicine Project represents our present and our future as a society. Its goal is to promote personalized medicine to further improve people’s health while ensuring equity,” it explains. Daniel Ruiz, Deputy Director General of International Research Programs and Institutional Relations at ISCIII. “EP PerMed represents a very important part of the various initiatives linked to the building of the European Health Union, which aims to promote the coordinated and joint response of Member States to the research and application of biomedical and health developments. The common challenge is to ensure that scientific knowledge benefits the economy and society,” he concludes.

See also  “We Do Science” Conference - ULL

You may also like…

Leave a Reply

Your email address will not be published. Required fields are marked *